GHK-Cu: The Anti-Aging Peptide Backed by Science

GHK Cu (glycyl L histidyl L lysine:copper(II)) is a naturally occurring tripeptide, just three amino acids, bound to a copper ion. It was first identified in human plasma by Loren Pickart in 1973 (Pickart et al., 2012, Oxid Med Cell Longev; PMID: 22666519). The discovery happened when researchers noticed that liver tissue from young adults could stimulate old liver tissue to produce proteins characteristic of younger tissue, and the active factor turned out to be this remarkably small peptide copper complex (Pickart, 2008, Journal of Biomaterials Science, Polymer Edition; PMID: 18644225).

What makes GHK Cu scientifically fascinating is not just what it does but how much it does relative to its size. Gene expression analyses suggest GHK influences the activity of a large number of human genes, shifting many toward patterns associated with tissue repair (Pickart et al., 2015, BioMed Research International; PMID: 26236730).

Its best documented function is promoting wound healing. In laboratory and animal studies, GHK-Cu accelerates multiple phases of wound healing (Pickart et al., 2015, Biomed Res Int; PMID: 26236730). It also appears to modulate inflammation and oxidative stress in laboratory studies (Pickart et al., 2012, Oxidative Medicine and Cellular Longevity; PMID: 22666519). In cell studies, it stimulates collagen synthesis, the structural protein that forms the scaffold for tissue repair and gives skin its tensile strength (Pickart et al., 2015, Biomed Res Int; PMID: 26236730). It promotes new blood vessel formation, ensuring adequate oxygen and nutrient delivery to healing tissue. It also stimulates production of decorin and glycosaminoglycans, extracellular matrix components important for tissue hydration and structure (Pickart et al., 2015, Biomed Res Int; PMID: 26236730).

The Broad Institute's Connectivity Map data provided remarkable insights into GHK Cu's gene expression effects. Analysis by Campbell et al. (Gene expression analyses reviewed by Pickart and colleagues suggest that GHK influences genes involved in DNA repair, antioxidant defense, the ubiquitin-proteasome system, and tissue repair signaling (Pickart et al., 2014, Biomed Res Int; PMID: 25302294). Its proponents suggest GHK-Cu acts as a broad restorative signal, since in laboratory data it alters the expression of thousands of genes, although the clinical significance of these changes is unproven (Pickart et al., 2015, Biomed Res Int; PMID: 26236730).

The copper ion in GHK Cu is not merely along for the ride. Copper is an essential cofactor for numerous enzymes including superoxide dismutase (antioxidant defense), lysyl oxidase (collagen cross linking), cytochrome c oxidase (mitochondrial energy production), and tyrosinase (melanin synthesis). GHK binds copper with an affinity similar to the copper transport site on albumin and has been proposed to help deliver copper to sites of tissue repair (Pickart, 2008, J Biomater Sci Polym Ed; PMID: 18644225).

Most of the human data for GHK-Cu come from small studies of topical cosmetic products (Najafi et al., 2026, Arch Intern Med Res; PMID: 42787770). Small controlled studies of topical GHK-Cu on aged skin have reported tighter skin, improved elasticity and firmness, and fewer fine lines and wrinkles (Pickart, 2008, J Biomater Sci Polym Ed; PMID: 18644225)). ). GHK-Cu has also shown promise for hair growth in laboratory studies, where it increased hair follicle size, and it has been reported to improve hair transplant outcomes (Pickart, 2008, J Biomater Sci Polym Ed; PMID: 18644225). A study by Pyo et al. (A 2007 laboratory study found that a related copper tripeptide, AHK-Cu, stimulated elongation of human hair follicles grown outside the body (Pyo et al., 2007, Arch Pharm Res; PMID: 17703734).

Beyond topical use, injectable GHK Cu is used in some clinical settings for systemic anti aging, anti inflammatory, and tissue repair purposes. The evidence base for systemic use is less developed than for topical applications. Preclinical data suggest GHK-Cu may support lung tissue repair, bone healing, and nervous system protection, but human clinical trials for these indications are limited or absent (Pickart et al., 2018, Int J Mol Sci; PMID: 29986520).

For delivery, topical application is the most established route, available in creams, serums, and post-procedure products (Najafi et al., 2026, Arch Intern Med Res; PMID: 42787770)%. Subcutaneous injection is used in some clinical settings, but human pharmacokinetic, dosing, and outcome data for this route are very limited (Mateescu et al., 2026, Pharmaceutics; PMID: 42797253). Microneedling greatly increased GHK-Cu skin uptake in laboratory and animal-skin models, but this combination has not yet been tested in an adequately powered human trial (Najafi et al., 2026, Arch Intern Med Res; PMID: 42787770).

Topical GHK Cu has an excellent safety profile with decades of cosmeceutical use (Pickart et al., 2012, Oxid Med Cell Longev; PMID: 22666519). Allergic reactions are rare. For injectable use, published human safety data are very limited (Mateescu et al., 2026, Pharmaceutics; PMID: 42797253). Because GHK-Cu contains copper, excess copper exposure is a theoretical concern at high doses.

GHK-Cu stands out for the breadth of biological effects reported in laboratory studies relative to its small size (Pickart et al., 2018, Int J Mol Sci; PMID: 29986520). For topical anti-aging use the evidence is the most developed, but it still rests largely on small studies (Najafi et al., 2026, Arch Intern Med Res; PMID: 42787770). For systemic use, the science is promising but awaits more rigorous human trials. It remains one of the most scientifically interesting peptides in the regenerative medicine toolkit.